Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2 [PDF]
Marc Billaud +9 more
openalex +1 more source
ABSTRACT This report describes a rare case of alveolar rhabdomyosarcoma initially presenting with clinical features resembling an endodontic lesion. A 15‐year‐old male presented with progressive right maxillary swelling initially treated as a dental abscess.
Saliha Akçay Köprücü +3 more
wiley +1 more source
Bone marrow biopsies in patients with undifferentiated carcinoma of the nasopharyngeal type [PDF]
C Micheau +7 more
openalex +1 more source
PERBEDAAN SKOR GERIATRIC DEPRESSION SCALE PADA PASIEN USIA LANJUT DENGAN KANKER KEPALA DAN LEHER YANG BELUM DAN SEDANG MENJALANI RADIOTERAPI [PDF]
Background. There has been a constant rise in the elderly population number throughout the world, more so in the developing countries. This growth is paralleled with rapid increase in disease prevalence, head and neck cancer being one of them.
Saktini, Fanti +2 more
core
Antimicrobial prescribing guidelines for horses in Australia
The growing problem of antimicrobial resistance also affects equine veterinarians with increasing frequency. Antimicrobial stewardship and responsible prescribing are essential for a future in which effective antimicrobials are available, as it is unlikely that new antimicrobials will become available for use in horses.
L Hardefeldt +18 more
wiley +1 more source
Intensive Nitrogen Mustard Therapy with Abdominal Aortic Occlusion in Nasopharyngeal Carcinoma
Peter Clifford +2 more
openalex +1 more source
Keratin and involucrin immunohistochemistry of nasopharyngeal carcinoma [PDF]
Hideko Kamino, Shirley J. Huang, Yao Fu
openalex +1 more source
Construction, expression, and characterization of rSEA-EGF and in vitro evaluation of its antitumor activity against nasopharyngeal cancer [PDF]
He, Ying +9 more
core +2 more sources
Immune checkpoint inhibitors (ICIs) have been a breakthrough in cancer therapy, inducing durable remissions in responding patients. However, they are associated with variable outcomes, spanning from disease hyperprogression to complete responses with the onset of immune‐related adverse events.
Mikhaël Attias, Ciriaco A. Piccirillo
wiley +1 more source

